BioSpace News Archive

Prelude Therapeutics Incorporated a clinical-stage precision oncology company, announced that Jane Huang, M.D., has been appointed to the newly created position of President and Chief Medical Officer, effective on April 4, 2022.

Araris Biotech AG, a company pioneering a proprietary antibody-drug conjugate (ADC)-linker technology, today announced the company will be presenting a scientific poster, as well as presenting preclinical data at the Minisymposium during the American Association for Cancer Research (AACR) Annual Meeting 2022.

Denali Therapeutics Inc. (NASDAQ: DNLI), a biopharmaceutical company developing a broad portfolio of product candidates engineered to cross the blood-brain barrier (BBB) for neurodegenerative diseases, today announced that dosing has begun in a Phase 1/2 clinical trial of DNL593 (PTV:PGRN) for the potential treatment of frontotemporal dementia (FTD) caused by mutations in the granulin gene (GRN).

Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced it has entered into a contract with Vizient, a leading healthcare performance improvement company in the U.S., to add Touch Surgery™ Enterprise to Vizient’s offerings, which serve more than half the nation’s healthcare providers.

Myeloid Therapeutics, Inc. (“Myeloid”), a clinical stage mRNA-immunotherapy company developing novel therapies for cancer and autoimmune diseases, today announced that it will present two late-breaking posters at the American Association for Cancer Research (AACR) Annual Meeting taking place April 8-13, 2022 in New Orleans, LA.

Harmony Biosciences Holdings, Inc., a pharmaceutical company dedicated to developing and commercializing innovative therapies for patients with rare neurological diseases, announced that its executive leaders will participate in the following upcoming virtual conferences.

Amsterdam, the Netherlands – Royal Philips, a global leader in health technology, has announced new research evaluating mobile cardiac outpatient telemetry as a first-line diagnostic ambulatory monitoring solution with post-cryptogenic stroke patients.

West Pharmaceutical Services, Inc., a global leader in innovative solutions for injectable drug administration, announced that it will participate in the KeyBanc Capital Markets Life Sciences & MedTech Investor Forum taking place virtually on March 23, 2022.

Seneca Therapeutics, Inc. announced the publication of an abstract “Oncolytic Seneca Valley Virus overcomes checkpoint inhibitor resistance and demonstrates a systemic anti-tumor immune response in a syngeneic pancreatic cancer murine model” at the upcoming American Association for Cancer Research meeting in New Orleans, LA.

Design Therapeutics, Inc. today announced that preclinical data supporting the potential of the company’s novel GeneTAC™ small molecules to correct the most common underlying genetic cause of Fuchs endothelial corneal dystrophy (FECD) will be presented at the Association for Research in Vision and Ophthalmology 2022 Annual Meeting (ARVO 2022).